ELAN Elanco Animal Health Incorporated
ELAN Elanco Animal Health Incorporated
Healthcare · Drug Manufacturers - Specialty & Generic
Desk view
Market read
POC $22.44 · VWAP $23.42 · +0.6% vs 12m avg buyer
Insiders quiet 0 buy / 0 sell · Form 4, 90d
Cluster
Coverage
1 related campaign
ELAN Price Structure
Loading timeframes…
Peers
Every watchlist ELAN belongs to, members best 30-day change first — ELAN highlighted in place. Each pill: 30d change, 1d/7d, and a close spark over the last 30 calendar days (~21 sessions); hover for price, RSI, and the full chart.
@livestock-disease
Reported the quarter ending 2026-06-30: revenue $1.37B, diluted EPS $0.11, net income $54M (SEC filing). Across the print the stock moved -5.5% (close before → first close after).
full note →Against street estimates
How ELAN's reported EPS compared with analyst consensus. Street estimates are single-source vendor consensus (yfinance). Actuals are vendor consensus-basis EPS (often non-GAAP); edgarEps is GAAP diluted from filings — disputed flags large disagreement only. EPS only.
ELAN research tape
21 dated scans, research, and events, newest first — the full record. Desk commentary and scheduled prints sit in their own panes.